Team creates powerful computational tool to help researchers rapidly screen molecules for anti-COVID properties

A year into the COVID-19 pandemic, mass vaccinations have begun to raise the tantalizing prospect of herd immunity that eventually curtails or halts the spread of SARS-CoV-2. But what if herd immunity is never fully achieved—or if the mutating virus gives rise to hyper-virulent variants that diminish the benefits of vaccination?

This post was originally published on this site

KeyLegal.ca - Consult a Lawyer Online in a variety of legal subjects